{"filings":[{"id":759037,"accession_number":"0000049071-26-000027","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2026-06-01T10:37:55+00:00","items":["7.01"],"status":"ready","headline":"Humana reaffirms FY2026 EPS guidance of at least $8.36 GAAP and $9.00 adjusted","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirms prior guidance issued April 29, 2026; no change to FY2026 outlook.","GAAP EPS target at least $8.36; adjusted (non-GAAP) EPS target at least $9.00.","Adjusted EPS excludes $0.30 amortization, $(0.28) put/call adjustments, $0.81 value creation initiatives, and $(0.19) net tax impact.","Management to meet investors June 1-30, 2026; no additional material updates provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":527679,"accession_number":"0000049071-26-000025","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2026-05-19T20:30:11+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Humana issues $1.5B in P-Caps via two trusts, gains option to issue senior notes up to $1.5B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Horseshoe Funding Trust I issued 750,000 P-Caps ($750M) for 6.062% Senior Notes due 2036; Trust II issued 750,000 P-Caps ($750M) for 6.887% Senior Notes due 2055.","Company may draw up to $750M per trust over 10-year (2036) or 30-year (2055) period, paying facility fees of 1.661% and 1.916% per annum on unused portion.","Full mandatory exercise of issuance rights triggered if Humana's consolidated net worth drops below $4.0 billion or upon certain defaults/change-of-control events.","Change-of-control triggers require Trusts to repurchase P-Caps at 101% and Humana to repurchase Senior Notes at 101% plus accrued interest.","Proceeds from P-Caps invested in U.S. Treasury strips; P-Caps mandatorily redeemable at maturity (2036 or 2055) or earlier upon redemption of Senior Notes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98181,"accession_number":"0000049071-26-000021","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Humana 1Q26 adj EPS $10.31; affirms FY adj EPS at least $9.00; revises GAAP guidance down","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["1Q26 GAAP EPS $9.83, Adjusted EPS $10.31 (high end of ~110-115% of FY); 1Q25 GAAP $10.30, Adj $11.58.","Revenue $39.6B vs $32.1B YoY; Insurance benefit ratio 89.4% (guidance 'just under 90%').","Affirms FY2026 adjusted EPS guidance at least $9.00; revises GAAP EPS to at least $8.36 from at least $8.89.","CenterWell added 110,500 patients sequentially (+22%), incl. ~59,000 from MaxHealth acquisition; state contracts membership up ~50,000.","Insurance President George Renaudin to retire June 29, 2026; Aaron Martin to succeed, John Barger to lead Medicare Advantage."],"consensus_eps_estimate":null,"consensus_eps_actual":9.83,"consensus_revenue_estimate":null,"consensus_revenue_actual":39648000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98180,"accession_number":"0000049071-26-000015","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2026-04-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Humana annual meeting: all director nominees elected, auditor ratified, say-on-pay approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 10 director nominees elected; Dr. Wayne A.I. Frederick received 85.2M for, 16.9M against (16.6% withheld).","PricewaterhouseCoopers ratified as auditor for 2026 with 102.4M for, 5.4M against.","Non-binding say-on-pay approved: 97.2M for, 4.7M against (95.4% support).","Humana 2026 Stock Incentive Plan approved: 97.7M for, 4.3M against.","Stockholder proposal on golden parachutes rejected: 42.0M for, 59.1M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98179,"accession_number":"0000049071-26-000013","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2026-04-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Humana elects Robert S. Field to board, effective after 2026 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded from 10 to 11 directors; Field elected effective April 16, 2026.","Field is Principal & Managing Member of ηMed Capital Management, a healthcare-services investment firm.","Board determined Field qualifies as independent under NYSE standards; no committee assignments yet.","Field will receive restricted stock units under Humana's director compensation program.","Field previously served at Luxor Capital and McKinsey; brings investor and legal expertise."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113489,"accession_number":"0001628280-26-016031","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2026-03-09T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Humana issues $1.0B in 6.625% junior subordinated notes due 2056","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Net proceeds ~$986M after discounts and expenses; proceeds for general corporate purposes including commercial paper repayment.","Notes pay 6.625% fixed through Sep 15, 2031, then reset every 5 years at 5yr UST + 2.891% with a 6.625% floor.","Issued under amended indenture with Bank of New York Mellon as trustee; unsecured and subordinated to senior debt.","Optional deferral of interest for up to 10 consecutive years if no event of default."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113488,"accession_number":"0000049071-26-000011","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Humana reaffirms FY 2026 EPS guidance of at least $8.89 GAAP / $9.00 adjusted","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Guided diluted GAAP EPS at least $8.89, adjusted EPS at least $9.00 for FY 2026.","Reaffirmation aligns with prior guidance issued February 11, 2026; no change expected.","Management meeting with investors and analysts from March 2 to March 31, 2026.","Adjusted EPS excludes $0.15 amortization and $0.04 net tax impact."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113487,"accession_number":"0000049071-26-000005","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2026-02-11T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Humana reports Q4 GAAP loss per share of $6.61, FY2025 adjusted EPS $17.14; FY2026 guided at least $8.89 GAAP","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["4Q25 GAAP net loss per share $6.61; adjusted net loss per share $3.96; FY2025 GAAP EPS $9.84, adjusted EPS $17.14.","FY2026 guidance: GAAP EPS at least $8.89, adjusted EPS at least $9.00, decline due to Star Ratings headwind.","Insurance segment benefit ratio FY2025 90.4% slightly above guidance; individual MA membership up ~20% to 6.28M in Jan 2026.","CenterWell added 100,600 patients in Senior Primary Care (over 25% growth); Medicaid footprint now 13 states.","FY2025 operating cash flows $921M vs $2,966M prior year; debt-to-capitalization 41.1%."],"consensus_eps_estimate":null,"consensus_eps_actual":9.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":129664000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129886,"accession_number":"0000049071-25-000061","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-12-16T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Humana: Insurance Segment President Renaudin to retire by Q3 2026; appoints successors, reaffirms guidance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["George Renaudin, Insurance Segment President, to retire by Q3 2026 after a 29-year career.","Aaron Martin (ex-Amazon VP Healthcare) joins Jan 2026 as President of Medicare Advantage, later to become Insurance Segment President.","John Barger, currently President of Medicaid/Dual Eligible, will be promoted to President of Medicare Advantage after Renaudin's retirement.","Company reaffirms FY2025 guidance: GAAP EPS ~$12.26, adjusted EPS ~$17.00."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129885,"accession_number":"0000049071-25-000059","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-12-01T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Humana reaffirms FY 2025 guidance: GAAP EPS ~$12.26, Adjusted EPS ~$17.00","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Reaffirms diluted GAAP EPS guidance of approximately $12.26 for FY 2025.","Reaffirms Adjusted (non-GAAP) EPS guidance of approximately $17.00 for FY 2025.","Guidance consistent with November 5, 2025 press release; no change from prior outlook.","Reconciliation includes amortization ($0.42), put/call adjustments ($3.81), value creation ($2.65), and other items.","Senior management meeting investors between Dec 1-31, 2025 to discuss reaffirmed guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129884,"accession_number":"0000049071-25-000055","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Humana Q3 GAAP EPS $1.62 vs $3.98 prior year; affirms FY 2025 Adj. EPS $17.00; MA membership decline narrowed to ~425k","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $1.62, down 59% YoY from $3.98; Adjusted EPS $3.24 vs $4.16.","Revenue $32.6B (+11% YoY); Insurance segment benefit ratio 91.1% vs 89.9%.","FY 2025 GAAP EPS guidance revised to ~$12.26 from ~$13.77; Adjusted EPS reaffirmed at ~$17.00.","Individual Medicare Advantage membership decline expected ~425k vs prior ~500k; better retention & sales.","CenterWell Primary Care grew 15% (+56,600 patients) YTD; preparing for 2026 Medicaid expansions in MI, IL, SC."],"consensus_eps_estimate":null,"consensus_eps_actual":16.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":97149000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129883,"accession_number":"0000049071-25-000048","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-10-02T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Humana prelim 2026 MA Star Ratings: 20% members in 4+ star plans, avg 3.61; reaffirms FY2025 EPS guidance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["1.2M members (20%) in plans rated 4+ stars for 2026; average Star rating 3.61, consistent with 2025.","14% of members in 4.5 star plans in 2026, up from 3% in 2025.","Affirms FY2025 GAAP EPS ~$13.77 and adjusted EPS ~$17.00; no change to multiyear earnings plan.","Confident in 2026 Individual MA pricing/benefit design; expects double pre-tax margin ex-Stars and membership growth.","Anticipates return to Top Quartile for 2027 MA Star Ratings; contract diversification expected to raise % of members in 4+ star contracts for 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146472,"accession_number":"0000049071-25-000044","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-08-29T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Humana reaffirms FY2025 GAAP EPS ~$13.77, adjusted EPS ~$17.00","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Reaffirms FY2025 guidance: GAAP diluted EPS ~$13.77; adjusted EPS ~$17.00.","Guidance unchanged from July 30, 2025 press release and Q2 earnings call.","Company will not comment on 2026 MA Star Ratings until CMS final data release in October.","Reconciliation shows adjusted EPS excludes amortization, put/call adjustments, value creation initiatives, and impairment charges."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146471,"accession_number":"0000049071-25-000039","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Humana Q2 adjusted EPS $6.27; raises FY2025 adj. EPS guidance to ~$17.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 GAAP EPS $4.51; adjusted EPS $6.27 vs $6.96 YoY; revenue $32.4B up 10% YoY.","FY2025 adj. EPS guidance raised to ~$17.00 from ~$16.25; revenue guidance raised to at least $128B.","Insurance segment benefit ratio 89.9% in line with expectation; FY benefit ratio guidance affirmed at 90.1%-90.5%.","Individual Medicare Advantage membership decline now seen as up to 500k vs prior ~550k; exiting unprofitable plans.","CenterWell Primary Care sees FY net patient growth of 50k-70k, up from prior 30k-50k; Virginia Medicaid launched."],"consensus_eps_estimate":null,"consensus_eps_actual":14.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":64500000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164840,"accession_number":"0000049071-25-000026","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Humana reaffirms FY2025 GAAP EPS ~$14.68, adjusted EPS ~$16.25","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirmed FY2025 diluted EPS guidance of approx. $14.68 (GAAP) and $16.25 (adjusted, non-GAAP).","Guidance unchanged from the company's April 30, 2025 press release.","Investor Conference scheduled June 16, 2025 at 2:00 PM EST, accessible via live webcast."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164839,"accession_number":"0000895345-25-000200","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Humana enters new $5.0B credit revolver, upsizing from $2.642B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $5.0B unsecured revolver amends and restates existing $2.642B facility and replaces expired $2.1B 364-day facility.","No borrowings outstanding at signing; ~$14.7M in issued undrawn letters of credit, leaving ~$4.98B available capacity.","Facility includes incremental commitment option up to $1.0B; customary covenants include maximum debt-to-capitalization ratio.","Loans bear interest at Term SOFR, Daily Simple SOFR, or base rate plus spread; annual facility fee payable regardless of utilization."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164838,"accession_number":"0000049071-25-000021","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Humana Q1 GAAP EPS $10.30, Adjusted EPS $11.58; affirms FY adjusted EPS ~$16.25","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 GAAP EPS $10.30 vs $6.11 YoY; Adjusted EPS $11.58 vs $7.23 YoY; revenue $32.1B up 8.4%.","Insurance segment benefit ratio 87.4% in line with ~87.5% expectation; affirms FY 2025 benefit ratio guidance 90.1%-90.5%.","Revises FY 2025 GAAP EPS guidance to ~$14.68 from ~$15.88; affirms Adjusted EPS guidance ~$16.25.","Expects individual Medicare Advantage membership decline of ~550k in 2025 due to planned plan exits.","CenterWell selected as fulfillment pharmacy for NovoCare weight-loss drug; Illinois intends to award Dual Eligible SNP contract."],"consensus_eps_estimate":null,"consensus_eps_actual":10.3,"consensus_revenue_estimate":null,"consensus_revenue_actual":32112000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164837,"accession_number":"0000049071-25-000016","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-04-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Humana stockholders elect 11 directors, ratify auditor, approve say-on-pay at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 11 management director nominees elected; highest against vote was 6.04M for Karen W. Katz.","Ratification of PwC as auditor for FY2025 approved with 98.9M for, 6.3M against.","Advisory vote on executive compensation passed with 89.3M for, 10.6M against, 5.2M broker non-votes.","Quorum of 105.2M shares present; meeting held April 17, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182556,"accession_number":"0001628280-25-015646","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Humana issues additional $250M of 5.375% Senior Notes due 2031, total now $1.5B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Sold additional $250M of 5.375% Senior Notes due 2031 at 99.941% of par plus accrued interest.","Combined with $1.25B issued March 2024, total outstanding $1.5B; notes rank equally with unsecured unsubordinated debt.","Net proceeds estimated ~$247M; to be used for general corporate purposes, including possible repayment of existing indebtedness.","Underwriting agreement with J.P. Morgan and Barclays; notes under existing indenture; interest payable Apr/Oct starting Apr 15, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182555,"accession_number":"0001628280-25-010583","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Humana completes $1.25B debt offering to refinance 2025 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $750M of 5.550% Senior Notes due 2035 at 99.885% of par.","Issued $500M of 6.000% Senior Notes due 2055 at 98.951% of par.","Net proceeds of ~$1.231B after underwriter discounts and expenses.","Proceeds to repay $750M of 4.500% Senior Notes maturing April 2025 and for general corporate purposes.","Underwriters include Barclays, BofA, J.P. Morgan, Mizuho, and U.S. Bancorp."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182554,"accession_number":"0000049071-25-000009","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Humana reaffirms FY2025 GAAP EPS ~$15.88, adjusted ~$16.25","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirms FY2025 GAAP diluted EPS guidance of ~$15.88 and adjusted EPS of ~$16.25.","Adjusted EPS excludes $0.49 amortization of intangibles; net tax impact of ($0.12).","Guidance is consistent with the prior February 11, 2025 press release.","Senior management is meeting with investors and analysts from March 3–31, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182553,"accession_number":"0000049071-25-000004","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2025-02-11T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Humana reports Q4 GAAP loss per share of $5.76; guides FY 2025 adjusted EPS ~$16.25","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["4Q24 GAAP net loss per share of $5.76; adjusted net loss per share of $2.16; FY 2024 GAAP EPS $9.98, adjusted $16.21.","FY 2025 adjusted EPS guidance approx $16.25 (GAAP ~$15.88), roughly in line with FY 2024 adjusted EPS of $16.21.","Expects individual Medicare Advantage membership decline ~550,000 (~10%) from 2024 due to exit from unprofitable plans and counties.","Insurance segment adjusted benefit ratio 91.9% in Q4, including 20bp increase from Star Ratings investments.","CenterWell and Medicaid strategies expected to increase earnings contribution over mid to long term."],"consensus_eps_estimate":null,"consensus_eps_actual":9.98,"consensus_revenue_estimate":null,"consensus_revenue_actual":117761000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199142,"accession_number":"0000049071-24-000058","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-12-03T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Humana appoints Celeste Mellet as CFO; Susan Diamond to step down Jan 10, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Susan Diamond transitions to advisory role through Dec 31, 2025, after 18 years at Humana.","Celeste Mellet named CFO effective Jan 11, 2025; previously CFO at Global Infrastructure Partners and Evercore.","Mellet receives base salary of $975k, initial equity award of $6M, and sign-on payment of $7.3M.","Company reaffirms FY2024 adjusted EPS guidance of at least $16.00 and FY2025 outlook at least in line.","Humana targets an Investor Day in May 2025 for further strategic updates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199141,"accession_number":"0000049071-24-000051","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Humana Q3 GAAP EPS $3.98, Adjusted $4.16, down YoY; FY guidance at least $16 adjusted","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["3Q24 GAAP EPS $3.98 vs $6.71 YoY; adjusted EPS $4.16 vs $7.78.","FY2024 guidance: GAAP EPS at least $12.89, adjusted at least $16.00.","Raises 2024 individual Medicare Advantage membership growth to ~265,000 (+5%).","Benefit expense ratio 89.9% vs 86.6% YoY due to elevated medical cost trends.","Insurance segment income from operations $274M vs $722M YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":15.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":88548000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199140,"accession_number":"0000049071-24-000047","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-10-23T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Humana elects Gordon Smith (ex-JPMorgan executive) to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gordon Smith elected to Board effective October 23, 2024, expanding Board from 11 to 12 directors.","Smith is former Co-President & Co-COO of JPMorgan Chase (retired Jan. 2022) and an Operating Advisor at Clayton, Dubilier & Rice.","Board determined Smith independent under NYSE standards; no material transactions with Humana.","Compensation follows standard director policies, including restricted stock unit grant; no committee assignments yet.","Smith brings deep operational expertise in consumer business, brand management, and digital transformation for Humana's growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199139,"accession_number":"0000049071-24-000045","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-10-02T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Humana's 2025 Medicare Advantage Star Ratings drop sharply, impacting 2026 bonus payments","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Only 25% of Humana's MA members are in plans rated 4 stars+ for 2025, down from 94% in 2024.","Contract H5216, covering ~45% of MA membership, fell to 3.5 stars from 4.5 in 2024.","Humana is appealing potential CMS calculation errors and expects no impact on 2024-2025 financial results.","The company faces increased risk in achieving its individual MA margin target of at least 3% by 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215197,"accession_number":"0000049071-24-000042","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-09-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Humana reaffirms FY2024 guidance: GAAP EPS ~$12.81, adjusted EPS ~$16.00","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Guidance unchanged from July 31, 2024 press release; FY2024 GAAP EPS ~$12.81.","Adjusted EPS ~$16.00; adjustments include amortization $0.50, put/call $1.65, exit commercial medical $1.21, value creation $0.80, net tax -$0.97.","Management reaffirms guidance in investor meetings Sept 3-30, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215196,"accession_number":"0000049071-24-000037","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Humana Q2 GAAP EPS $5.62, Adj EPS $6.96; cuts FY GAAP guidance to ~$12.81","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 GAAP EPS $5.62 vs $7.66 YoY; adjusted EPS $6.96 vs $8.94 YoY; revenue $29.54B vs $26.75B.","FY 2024 GAAP EPS guidance revised to ~$12.81 from ~$13.93; adjusted EPS guidance reaffirmed at ~$16.00.","Benefits expense ratio rose to 89.0% from 86.3% YoY due to elevated Medicare Advantage medical cost trends.","Individual Medicare Advantage annual membership growth estimate raised by 75k to ~225k (4.2% growth)."],"consensus_eps_estimate":null,"consensus_eps_actual":11.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":59151000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234478,"accession_number":"0001193125-24-155138","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Humana enters $2.108B 364-day revolver and upsizes 5-year facility to $2.642B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New 364-day unsecured revolving credit facility of $2,107,812,500, replacing a $1.5B facility.","Amendment to existing 5-year revolver increases commitments from $2.5B to $2,642,187,500.","No borrowings outstanding; only $18.1M in issued and undrawn letters of credit as of May 31, 2024.","Borrowings bear interest at Term SOFR or base rate plus spread; subject to customary covenants including max debt-to-capitalization.","Total availability now ~$4.734B; proceeds for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234477,"accession_number":"0000049071-24-000027","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-06-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Humana Reaffirms FY 2024 Guidance of ~$13.93 GAAP EPS and ~$16.00 Adjusted EPS","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirmed FY 2024 diluted GAAP EPS guidance of approximately $13.93 and adjusted EPS of approximately $16.00.","Guidance reiterated during investor meetings from June 3 to June 28, 2024.","Adjusted EPS excludes amortization of intangibles ($0.49), put/call adjustments ($1.08), employer group exit ($0.90), value creation initiatives ($0.24), and net tax impact (-$0.64).","Prior guidance originally issued in April 24, 2024 press release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234476,"accession_number":"0000049071-24-000025","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Jim Rechtin to become Humana CEO on July 1; Broussard steps down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jim Rechtin named President and CEO effective July 1, 2024; succeeds Bruce Broussard.","Broussard resigns from Board on July 1; serves as strategic advisor through 2026.","Rechtin joined Humana as President/COO in January 2024 as part of planned transition.","Broussard's agreement provides no severance; continues equity vesting and VSP hourly pay.","Rechtin will join Humana Board effective July 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234475,"accession_number":"0000049071-24-000021","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-04-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Humana Q1 GAAP EPS $6.11 vs $9.87 YoY; guidance revised down on GAAP but adjusted affirmed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $6.11, down from $9.87 YoY; adjusted EPS $7.23 vs $9.38 YoY.","Revenue $29.6B, up from $26.7B YoY; benefit ratio rose to 88.9% from 85.5%.","FY 2024 GAAP EPS guidance lowered to ~$13.93 from ~$14.87; adjusted EPS affirmed at ~$16.00.","Individual Medicare Advantage membership growth raised by 50k to ~150k (2.8% annual).","Medicaid expansion with contract wins in Florida, Texas, and Virginia."],"consensus_eps_estimate":null,"consensus_eps_actual":6.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":29611000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234474,"accession_number":"0000049071-24-000017","cik":49071,"company_name":"HUMANA INC","ticker":"HUM","form_type":"8-K","filed_at":"2024-04-19T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Humana annual meeting elects all 11 directors; approves governance amendments and say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 11 director nominees elected; Karen W. Katz had highest against vote at 13.4M (84.2M for).","Ratification of PwC as auditor: 95.8M for, 7.5M against, 164k abstentions.","Advisory say-on-pay passed: 89.1M for, 8.4M against, 254k abstentions.","Amendment to limit officer liability (Proposal #4): 83.4M for, 14.2M against, passed.","Stockholder simple-majority vote proposal passed: 50.0M for, 47.5M against, 376k abstained."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":36771236070.96815,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}